Targeting ADAR1 Restores Interferon Signaling and Enhances Immunotherapy Response in Multiple Myeloma
Songze Leng, Yaoyao Tian, Yao Liu, Weiwei Zhao, Wei Wang · 2026
Read Targeting ADAR1 Restores Interferon Signaling and Enhances Immunotherapy Response in Multiple Myeloma by Songze Leng, Yaoyao Tian, Yao Liu, Weiwei Zhao, Wei Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13466300.txt.
Description
Songze Leng and colleagues target an RNA-editing enzyme that helps multiple myeloma hide from the immune system, in a 2026 study. The enzyme, ADAR1, runs high in malignant plasma cells and tracks with worse outcomes and fewer killer T cells inside tumors. Removing it changed the tumor's alarm signals.
Without ADAR1, loose double-stranded RNA inside cells bound a sensor called MDA5 more readily, restoring interferon signaling and boosting T cell growth and killing power. Cutting the sensor erased most of that gain, proving the pair forms one working axis. In animals, a drug that blocks the enzyme strengthened PD-1 immunotherapy, shrinking tumors and drawing in more T cells.
Catalog record
| CREATOR | Songze Leng, Yaoyao Tian, Yao Liu, Weiwei Zhao, Wei Wang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |